{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T07:23:44Z","timestamp":1763277824297,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.vhri.2023.08.007","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T07:46:07Z","timestamp":1699947967000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Decision-Utility Analysis of Empiric Treatment Versus Test and Treat Strategies for Helicobacter pylori in Patients With Duodenal Ulcer"],"prefix":"10.1016","volume":"39","author":[{"given":"Majid","family":"Alsahafi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Mosli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"Alkhowaiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fergal","family":"Donnellan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vhri.2023.08.007_bib1","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","article-title":"Functional gastroduode-nal disorders","volume":"130","author":"Tack","year":"2006","journal-title":"Gastroenterology"},{"issue":"suppl 1","key":"10.1016\/j.vhri.2023.08.007_bib2","first-page":"A149A","article-title":"The worldwide prevalence of dyspepsia: systematic review and meta-analysis","volume":"136","author":"Marwaha","year":"2009","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.vhri.2023.08.007_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2036.2004.01897.x","article-title":"Systemic review: the prevalence and clinical course of functional dyspepsia","volume":"19","author":"El-Serag","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.vhri.2023.08.007_bib4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/aje\/kwj129","article-title":"Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study","volume":"163","author":"Aro","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vhri.2023.08.007_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/gut.52.2.186","article-title":"Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults","volume":"52","author":"Rosenstock","year":"2003","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.vhri.2023.08.007_bib6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/ije\/25.3.638","article-title":"Risk factors for peptic ulcer in Shanghai","volume":"25","author":"Wang","year":"1996","journal-title":"Int J Epidemiol"},{"issue":"9","key":"10.1016\/j.vhri.2023.08.007_bib7","first-page":"1409","article-title":"Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials","volume":"93","author":"Laine","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.vhri.2023.08.007_bib8","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.1999.01214.x","article-title":"Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower\u00a0than previously estimated","volume":"94","author":"Ciociola","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.vhri.2023.08.007_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ajg.2011.480","article-title":"Management of patients with ulcer bleeding","volume":"107","author":"Laine","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.vhri.2023.08.007_bib10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1524-4733.2009.00524.x","article-title":"What is the best strategy for diagnosis and treatment of Helicobacter pylori in the prevention of recurrent peptic ulcer bleeding? A cost-effectiveness analysis","volume":"12","author":"Gen\u00e9","year":"2009","journal-title":"Value Health"},{"issue":"9","key":"10.1016\/j.vhri.2023.08.007_bib11","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1517\/14656566.4.9.1593","article-title":"Recurrent duodenal ulcer haemorrhage: a pharmacoeconomic comparison of various management strategies","volume":"4","author":"Ghoshal","year":"2003","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"10.1016\/j.vhri.2023.08.007_bib12","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/j.1572-0241.2002.05904.x","article-title":"The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage","volume":"97","author":"Ofman","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.vhri.2023.08.007_bib13","first-page":"31","article-title":"Low sensitivity of invasive tests for the detection of Helicobacter pylori infection in patients with bleeding ulcer","volume":"24","author":"Colin","year":"2000","journal-title":"Gastroenterol Clin Biol"},{"issue":"4","key":"10.1016\/j.vhri.2023.08.007_bib14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0889-8553(05)70153-9","article-title":"Accurate diagnosis of Helicobacter pylori with biopsy","volume":"29","author":"El-Zimaity","year":"2000","journal-title":"Gastroenterol Clin N Am"},{"issue":"12","key":"10.1016\/j.vhri.2023.08.007_bib15","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1046\/j.1365-2036.2000.00871.x","article-title":"Management of Helicobacter pylori in duodenal ulcer: a cost-effectiveness analysis","volume":"14","author":"Garc\u00eda-Alt\u00e9s","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.vhri.2023.08.007_bib16","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","article-title":"Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection","volume":"102","author":"Chey","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"suppl 2","key":"10.1016\/j.vhri.2023.08.007_bib17","first-page":"59","article-title":"The prevalence of Helicobacter pylori in\u00a0peptic ulcer disease","volume":"9","author":"Kuipers","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.vhri.2023.08.007_bib18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1046\/j.1440-1746.1999.02005.x","article-title":"Is Helicobacter pylori the primary cause of duodenal ulceration?","volume":"14","author":"Tovey","year":"1999","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.vhri.2023.08.007_bib19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00042737-200012060-00010","article-title":"Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese Population","volume":"12","author":"Nishikawa","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.vhri.2023.08.007_bib20","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1053\/j.gastro.2005.03.026","article-title":"Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study","volume":"128","author":"Hung","year":"2005","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.vhri.2023.08.007_bib21","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/jgh.12876","article-title":"A\u00a0multicenter prospective study on the prevalence of Helicobacter pylori-negative and nonsteroidal anti-inflammatory drugs-negative idiopathic peptic ulcers in Japan","volume":"30","author":"Kanno","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.vhri.2023.08.007_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/00365529309098356","article-title":"A\u00a0systematic overview (meta-analysis) of outcome measures in Helicobacter pylori gastritis trials and functional dyspepsia","volume":"199","author":"Veldhuyzen van Zanten","year":"1993","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"5","key":"10.1016\/j.vhri.2023.08.007_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2000.00744.x","article-title":"A\u00a0meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection","volume":"14","author":"Calvet","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.vhri.2023.08.007_bib24","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1046\/j.1365-2036.2001.01109.x","article-title":"A\u00a0meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer","volume":"15","author":"Leodolter","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.vhri.2023.08.007_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/den.12635","article-title":"Helicobacter pylori-negative and nonsteroidal anti-inflammatory drugs-negative idiopathic peptic ulcers show refractoriness and high recurrence incidence; multicenter follow-up study of peptic ulcers in Japan","author":"Kanno","year":"2016","journal-title":"Dig Endosc"},{"issue":"4","key":"10.1016\/j.vhri.2023.08.007_bib26","first-page":"CD003840","article-title":"Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people","volume":"4","author":"Ford","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.vhri.2023.08.007_bib27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1523-5378.2001.00037.x","article-title":"A\u00a0multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients","volume":"6","author":"Asaka","year":"2001","journal-title":"Helicobacter"},{"issue":"4","key":"10.1016\/j.vhri.2023.08.007_bib28","first-page":"695","article-title":"Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence","volume":"91","author":"Bianchi Porro","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.vhri.2023.08.007_bib29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1572-0241.2001.03516.x","article-title":"Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia","volume":"96","author":"Groeneveld","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.vhri.2023.08.007_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/archinte.159.2.149","article-title":"Screening for Helicobacter pylori and nonsteroidal anti-inflammatory drug use in medicare patients hospitalized with peptic ulcer disease","volume":"159","author":"Hood","year":"1999","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.vhri.2023.08.007_bib32","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archinte.1997.00440300102008","article-title":"Diagnosis and treatment of Helicobacter pylori infection among California Medicare patients","volume":"157","author":"Roll","year":"1997","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.vhri.2023.08.007_bib33","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1365-2036.2006.02899.x","article-title":"Long-term study of re-infection following successful eradication of Helicobacter pylori infection","volume":"23","author":"Cameron","year":"2006","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109923000845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109923000845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:14:30Z","timestamp":1761941670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109923000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":32,"alternative-id":["S2212109923000845"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2023.08.007","relation":{},"ISSN":["2212-1099"],"issn-type":[{"type":"print","value":"2212-1099"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decision-Utility Analysis of Empiric Treatment Versus Test and Treat Strategies for Helicobacter pylori in Patients With Duodenal Ulcer","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2023.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}